Insulin resistance in adipose tissue:: direct and indirect effects of tumor necrosis factor-α

被引:372
作者
Ruan, H
Lodish, HF
机构
[1] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA
[2] MIT, Dept Biol, Cambridge, MA 02142 USA
关键词
insulin resistance; obesity; free fatty acid; adipocyte-secreted factors; adipose tissue; tumor necrosis factor-alpha; NF-kappa B;
D O I
10.1016/S1359-6101(03)00052-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Insulin resistance is a fundamental defect that precedes the development of the full insulin resistance syndrome as well as P cell failure and type 2 diabetes. Tumor necrosis factor-alpha (TNF-alpha), a paracrine/autocrine factor highly expressed in adipose tissues of obese animals and human subjects, is implicated in the induction of insulin resistance seen in obesity and type 2 diabetes. Here, we review several molecular aspects of adipose tissue physiology, and highlight the direct effects of TNF-alpha on the functions of adipose tissue including induction of lipolysis, inhibition of insulin signaling, and alterations in expression of adipocyte important genes through activation of NF-kappaB, as well as their pertinence to insulin sensitivity of adipocytes. We also review the ability of TNF-alpha to inhibit synthesis of several adipocyte-specific proteins including Acrp30 (adiponectin) and enhance release of free fatty acids (FFAs) from adipose tissue, and discuss how these factors may act as systemic mediators of TNF-alpha and affect whole body energy homeostasis and overall insulin sensitivity. On the basis of these mechanisms, we examine the therapeutic potential of blocking specific autocrine/paracrine signaling pathways in adipocytes, particularly those involving NF-kappaB, in the treatment of type 2 diabetes. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:447 / 455
页数:9
相关论文
共 112 条
[71]   Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM [J].
Ofei, F ;
Hurel, S ;
Newkirk, J ;
Sopwith, M ;
Taylor, R .
DIABETES, 1996, 45 (07) :881-885
[72]   PPARγ and the treatment of insulin resistance [J].
Olefsky, JM ;
Saltiel, AR .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2000, 11 (09) :362-368
[73]   INSULIN-RESISTANCE AND NON-INSULIN-DEPENDENT DIABETES-MELLITUS - CELLULAR AND MOLECULAR MECHANISMS [J].
OLEFSKY, JM ;
NOLAN, JJ .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1995, 61 (04) :980S-986S
[74]   MECHANISMS OF INSULIN RESISTANCE IN NON-INSULIN-DEPENDENT (TYPE-II) DIABETES [J].
OLEFSKY, JM ;
CIARALDI, TP ;
KOLTERMAN, OG .
AMERICAN JOURNAL OF MEDICINE, 1985, 79 (3B) :12-22
[75]   Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin - Implications for metabolic regulation and bioactivity [J].
Pajvani, UB ;
Du, XL ;
Combs, TP ;
Berg, AH ;
Rajala, MW ;
Schulthess, T ;
Engel, J ;
Brownlee, M ;
Scherer, PE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (11) :9073-9085
[76]   GLUCOSE FATTY ACID CYCLE IN OBESITY AND MATURITY ONSET DIABETES MELLITUS [J].
RANDLE, PJ ;
GARLAND, PB ;
NEWSHOLME, EA ;
HALES, CN .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1965, 131 (A1) :324-+
[77]  
RANDLE PJ, 1963, LANCET, V1, P785
[78]   LOWERING OF PLASMA-GLUCOSE IN DIABETIC RATS BY ANTILIPOLYTIC AGENTS [J].
REAVEN, GM ;
CHANG, H ;
HO, H ;
JENG, CY ;
HOFFMAN, BB .
AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 254 (01) :E23-E30
[79]   PATHOPHYSIOLOGY OF INSULIN-RESISTANCE IN HUMAN-DISEASE [J].
REAVEN, GM .
PHYSIOLOGICAL REVIEWS, 1995, 75 (03) :473-486
[80]   ROLE OF INSULIN RESISTANCE IN HUMAN-DISEASE (SYNDROME-X) - AN EXPANDED DEFINITION [J].
REAVEN, GM .
ANNUAL REVIEW OF MEDICINE, 1993, 44 :121-131